MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The spectrum of composite autonomic severity score in SCA1, SCA2 and SCA3 patients

D. Tamuli, A. Godiyal, A. Jaryal, A. Srivastava, K. Deepak (New Delhi, India)

Meeting: 2017 International Congress

Abstract Number: 798

Keywords: Autonomic dysfunction

Session Information

Date: Wednesday, June 7, 2017

Session Title: Ataxia

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To analyze composite autonomic severity score in patients of spinocerebellar ataxia types 1, 2 and 3.

Background: Spinocerebellar ataxia (SCA) is a progressive neurodegenerative disorder characterized by autonomic failure. There is paucity of literature for quantification of autonomic failure applying validated score in SCA. The Composite Autonomic Severity Score (CASS) was developed for laboratory quantification of autonomic failure as a single validated score. This also standardizes for the confounding effects of age and gender. In this context, we evaluated CASS in patients of SCA1, 2 and 3.

Methods: Continuous HR and BP were recorded to determine autonomic function in genetically confirmed SCA1 (n=31, age=35.3±7.82 yrs), SCA2 (n=40, age=33.25±10.45 yrs) and  SCA3 (n=9, age=37.11±9.21 yrs) patients. CASS ranges from 0 to 10 and constitutes of sudomotor (0–3), cardiovagal (0–3), and adrenergic (0–4) subscores. The analysis of CASS was done by using MATLAB (R2015a).

Results: The mean total CASS was 4.45±1.69 in SCA1, 4.6±1.26 in SCA2 and 3.78±1.2 in SCA3. Mild autonomic failure were more in SCA3 (44.44%; 4/9) than SCA1 and SCA2. Most of the patients had moderate autonomic failure such as 80.65% (25/31) in SCA1, 85% (34/40) in SCA2 and 55.55% (5/9) in SCA3. More cases of severe failure were seen in SCA1 (2/31) than SCA2 (1/40) whereas none in SCA3 [Table].

Conclusions: Our data suggests moderate generalized autonomic failure (in SCA1 and SCA2) and mild failure (in SCA3) as determined by CASS. This may be a useful index imparting the clinical diagnosis of SCA1, SCA2 and SCA3.

References: 1. Novak P. Quantitative autonomic testing. JoVE (Journal of Visualized Experiments). 2011 Jul 19(53):e2502-e2502.

2. Low PA. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. InMayo Clinic Proceedings 1993 Aug 31 (Vol. 68, No. 8, pp. 748-752). Elsevier.

To cite this abstract in AMA style:

D. Tamuli, A. Godiyal, A. Jaryal, A. Srivastava, K. Deepak. The spectrum of composite autonomic severity score in SCA1, SCA2 and SCA3 patients [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/the-spectrum-of-composite-autonomic-severity-score-in-sca1-sca2-and-sca3-patients/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-spectrum-of-composite-autonomic-severity-score-in-sca1-sca2-and-sca3-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley